• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » How K2M tackled UDI and what comes next with help from Reed Tech

How K2M tackled UDI and what comes next with help from Reed Tech

September 26, 2018 By Sponsored Content

Mark Zellers, Quality Assurance Specialist at K2M, is responsible for ensuring his company’s data is accurate and kept up-to-date with all sorts of outside stakeholders. One of his colleagues handles internal data management and Zellers ensures it gets to the people who need it outside K2M. A big challenge facing his team came in 2015, when labelers of Implantable, Life-Supporting, of Life-Sustaining (IL/LS/LS) devices faced a compliance deadline from FDA to assign Unique Device Identifiers (UDIs) to their products, update their labels and submit the data records to the agency.

Now, Zellers and his teammates face additional demands for their product data. Customers are requesting data through the Global Data Synchronization Network (GDSN) for use in their product catalogue systems, the National Health Service (NHS) in the U.K. is requesting a similar, but distinct, dataset for their eProcurement program and the new EU MDR data submission requirements loom large on the horizon. Zellers spoke with the team at Reed Tech® to share his challenges and lessons learned from the approach K2M is taking to ensure the data needs of all its downstream stakeholders are being met.

This is an excerpt from a larger case study. You can access the full document here.

Sponsored content by K2M

Filed Under: Sponsored Content Tagged With: K2M, reed tech

More recent news

  • Abbott rolls out SimpleScreen colorectal cancer blood test developed by Freenome
  • Terumo to buy Arsenal Medical and its liquid embolic brain bleed system
  • MassDevice parent Arrowfly is launching AI for Engineers
  • Smart ring maker Oura postpones anticipated IPO
  • Medtronic gains regulatory wins for latest cardiac ablation software

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy